Samjin Pharmaceutical Appoints Daehyun Kim as Head of CH Division

Former Head of OTC Marketing at Donghwa Pharmaceutical

25 Years of Experience in OTC and THC Marketing

Strengthening Competitiveness of Leading Brands Such as "Geborin" and "Anjeongae" and Exploring New Business Opportunities

Samjin Pharmaceutical announced on August 11 that it has appointed Daehyun Kim, Executive Director, as the head of the Consumer Healthcare (CH) Division to strengthen its CH business.

Daehyun Kim, Executive Director at Samjin Pharmaceutical. Samjin Pharmaceutical

Executive Director Kim graduated from the College of Pharmacy at Seoul National University and obtained a pharmacist license. He has gained practical experience in hospitals and pharmacies, and has previously served as Head of Marketing Planning at Hanmi Group's Onlinepharm and Head of OTC Marketing at Donghwa Pharmaceutical. He was responsible for the overall operations of the OTC business, including product planning and the development and execution of sales strategies.

At Donghwa Pharmaceutical, he oversaw OTC operations by formulating brand positioning and marketing strategies based on consumer data analysis. He also participated in expanding online and overseas sales channels and in launching new businesses such as dermocosmetics and pet healthcare.

With the appointment of Executive Director Kim, Samjin Pharmaceutical plans to enhance the competitiveness of major brands such as "Geborin" and "Anjeongae," and to expand its consumer healthcare business by launching new categories.

Sangjin Kim, CEO of Samjin Pharmaceutical, said, "We expect the addition of Executive Director Daehyun Kim, who has extensive experience in the pharmaceutical industry and a deep understanding of both consumers and the pharmaceutical sector, will help strengthen our brand competitiveness," adding, "We will pursue growth strategies tailored to market changes."

This content was produced with the assistance of AI translation services.